DK1027063T3 - Mannosereceptorbærende cellelinje og antigensammensætning - Google Patents

Mannosereceptorbærende cellelinje og antigensammensætning

Info

Publication number: DK1027063T3
Authority: DK; Denmark
Prior art keywords: cell line; mannose receptor; antigen composition; antigen; carrying cell
Prior art date: 1997-09-29

Application number

DK98947738T

Other languages

Danish (da)

English (en)

Inventor

Vasso Apostolopoulos

Ian F C Mckenzie

Geoffrey A Pietersz

Original Assignee

Macfarlane Burnet Inst For Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-29

Filing date

1998-09-29

Publication date

2009-06-02

1998-09-29 Application filed by Macfarlane Burnet Inst For Med filed Critical Macfarlane Burnet Inst For Med

2009-06-02 Application granted granted Critical

2009-06-02 Publication of DK1027063T3 publication Critical patent/DK1027063T3/da

Links

239000000427 antigen Substances 0.000 title abstract 3
108091007433 antigens Proteins 0.000 title abstract 3
102000036639 antigens Human genes 0.000 title abstract 3
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 title abstract 2
229920001282 polysaccharide Polymers 0.000 abstract 3
210000000612 antigen-presenting cell Anatomy 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
108010031099 Mannose Receptor Proteins 0.000 abstract 1
150000001299 aldehydes Chemical class 0.000 abstract 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4256—Tumor associated carbohydrates
- A61K40/4257—Mucins, e.g. MUC-1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Virology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Microbiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Mycology (AREA)
Cell Biology (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Neurology (AREA)
Ophthalmology & Optometry (AREA)
AIDS & HIV (AREA)

DK98947738T 1997-09-29 1998-09-29 Mannosereceptorbærende cellelinje og antigensammensætning DK1027063T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6059497P	1997-09-29	1997-09-29
PCT/IB1998/001718 WO1999016455A1 (fr)	1997-09-29	1998-09-29	Composition d'antigene et de cellules portant des recepteurs de mannose

Publications (1)

Publication Number	Publication Date
DK1027063T3 true DK1027063T3 (da)	2009-06-02

Family

ID=22030506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98947738T DK1027063T3 (da)	1997-09-29	1998-09-29	Mannosereceptorbærende cellelinje og antigensammensætning

Country Status (10)

Country	Link
US (1)	US8771701B2 (fr)
EP (1)	EP1027063B1 (fr)
JP (2)	JP4669930B2 (fr)
AT (1)	ATE422893T1 (fr)
AU (1)	AU754065B2 (fr)
CA (1)	CA2304952C (fr)
DE (1)	DE69840578D1 (fr)
DK (1)	DK1027063T3 (fr)
ES (1)	ES2322212T3 (fr)
WO (1)	WO1999016455A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8021667B2 (en) *	1994-11-16	2011-09-20	Macfarlane Burnet Institute For Medical Research And Public Health Ltd	Compositions for immunotherapy and uses thereof
AU2001261383B2 (en)	2000-05-08	2004-10-21	Celldex Therapeutics, Inc.	Human monoclonal antibodies to dendritic cells
US7560534B2 (en)	2000-05-08	2009-07-14	Celldex Research Corporation	Molecular conjugates comprising human monoclonal antibodies to dendritic cells
AU2001263653B2 (en) *	2000-06-06	2006-06-29	Igavax Pty Ltd	Vaccine
AUPQ797700A0 (en)	2000-06-06	2000-06-29	Austin Research Institute, The	Vaccine
AU2004213749B2 (en)	2003-01-31	2010-02-25	Celldex Therapeutics, Inc.	Antibody vaccine conjugates and uses therefor
US9259459B2 (en)	2003-01-31	2016-02-16	Celldex Therapeutics Inc.	Antibody vaccine conjugates and uses therefor
EP2224954B1 (fr)	2007-11-07	2014-01-08	Celldex Therapeutics, Inc.	Anticorps qui se lient à la cellule dendritique et épithéliale 205 (dec-205) humaine
WO2009128952A2 (fr)	2008-04-18	2009-10-22	Vaxinnate Corporation	Compositions de protéines de papillomavirus et procédés d’utilisation
JP2014532799A (ja)	2011-11-09	2014-12-08	アセンド・バイオファーマシューティカルズ・リミテッド	免疫調節結合体
WO2014012933A1 (fr) *	2012-07-16	2014-01-23	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Procédé de génération de lignées cellulaires de macrophages non transformés
CN107108722A (zh) *	2014-02-06	2017-08-29	医化学创药株式会社	针对粘蛋白4(muc4)糖肽的抗体及其用途
CN104721795A (zh) *	2015-04-05	2015-06-24	四川双鑫生物科技有限公司	一种治疗百日咳的内服药物及其制备方法
IL297228A (en) *	2020-04-13	2022-12-01	Exoprother Medical Ltd	Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2279422A2 (fr)	1974-07-22	1976-02-20	Inst Nat Sante Rech Med	Forme pharmaceutique a base d'interferon
US4720386A (en) *	1976-11-24	1988-01-19	Mccollester Duncan L	Vaccine and method for immunotherapy of neoplastic disease
JPS61112023A (ja)	1984-11-05	1986-05-30	Tanabe Seiyaku Co Ltd	がん細胞傷害活性物質の新規製法
JP2594123B2 (ja)	1987-09-12	1997-03-26	株式会社林原生物化学研究所	減感作剤
EP0326111A3 (fr)	1988-01-29	1989-12-27	New York Blood Center, Inc.	Dérivés de peptide rendus immunogéniques lors de l'administration d'un alun comme adjuvant
US5047227A (en) *	1988-02-08	1991-09-10	Cytogen Corporation	Novel and improved antibodies for site specific attachment of compounds
JP2849683B2 (ja)	1988-03-11	1999-01-20	オオツカアメリカファーマシューティカル、インコーポレーティッド	「動物及びヒトのムチンを用い、並びに合成炭水化物−担体結合物を用いた免疫による、ヒト癌関連抗原に対するモノクローナル抗体」
US5229289A (en) *	1988-03-11	1993-07-20	The Biomembrane Institute	Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates
JPH01233219A (ja)	1988-03-12	1989-09-19	Nippon Oil & Fats Co Ltd	制癌剤組成物
AU620149B2 (en)	1988-08-18	1992-02-13	Vaxine Pty Ltd	Gamma inulin compositions
EP0442926A1 (fr)	1988-11-10	1991-08-28	Imperial Cancer Research Technology Limited	Polypeptides
ES2144414T3 (es)	1990-12-20	2000-06-16	Arch Dev Corp The University O	Control de la expresion de un gen por medio de una radiacion ionizante.
US6605712B1 (en)	1990-12-20	2003-08-12	Arch Development Corporation	Gene transcription and ionizing radiation: methods and compositions
US5432260A (en) *	1991-05-03	1995-07-11	Washington University	High affinity mannose receptor ligands
WO1993006858A1 (fr)	1991-10-09	1993-04-15	Dana Farber Cancer Institute, Inc.	Proteine associee au cancer du poumon
IL104382A0 (en)	1992-01-17	1993-05-13	Solvay Animal Health Inc	Vaccine containing acemannan as an adjuvant
JP3043888B2 (ja)	1992-02-20	2000-05-22	森永乳業株式会社	グルコマンナン部分加水分解物を有効成分とする大腸ガン予防剤
IT1262896B (it)	1992-03-06	1996-07-22		Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
US5820872A (en) *	1992-11-18	1998-10-13	Yale University	Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
WO1994013312A1 (fr)	1992-12-15	1994-06-23	The Board Of Trustees Of The Leland Stanford Junior University	Adressine vasculaire de muqueuses, adn codant ladite adressine et expression de ladite adressine
AUPM322393A0 (en)	1993-12-24	1994-01-27	Austin Research Institute, The	Mucin carbohydrate compounds and their use in immunotherapy
US8021667B2 (en) *	1994-11-16	2011-09-20	Macfarlane Burnet Institute For Medical Research And Public Health Ltd	Compositions for immunotherapy and uses thereof
US6017527A (en) *	1996-07-10	2000-01-25	Immunex Corporation	Activated dendritic cells and methods for their activation
EP0849275A1 (fr)	1996-09-26	1998-06-24	Rijksuniversiteit te Leiden	Peptides mannosylés
JP5246860B2 (ja)	2008-09-29	2013-07-24	株式会社前川製作所	急速熱処理装置及び急速熱処理装置用ノズル

1998
- 1998-09-29 CA CA2304952A patent/CA2304952C/fr not_active Expired - Fee Related
- 1998-09-29 JP JP2000513589A patent/JP4669930B2/ja not_active Expired - Fee Related
- 1998-09-29 AT AT98947738T patent/ATE422893T1/de active
- 1998-09-29 DE DE69840578T patent/DE69840578D1/de not_active Expired - Lifetime
- 1998-09-29 DK DK98947738T patent/DK1027063T3/da active
- 1998-09-29 AU AU94555/98A patent/AU754065B2/en not_active Ceased
- 1998-09-29 ES ES98947738T patent/ES2322212T3/es not_active Expired - Lifetime
- 1998-09-29 EP EP98947738A patent/EP1027063B1/fr not_active Expired - Lifetime
- 1998-09-29 WO PCT/IB1998/001718 patent/WO1999016455A1/fr not_active Ceased
2006
- 2006-11-17 US US11/561,204 patent/US8771701B2/en not_active Expired - Fee Related
2010
- 2010-10-06 JP JP2010226648A patent/JP5192020B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2304952A1 (fr)	1999-04-08
EP1027063B1 (fr)	2009-02-18
US8771701B2 (en)	2014-07-08
EP1027063A4 (fr)	2004-12-08
JP4669930B2 (ja)	2011-04-13
US20070071765A1 (en)	2007-03-29
ATE422893T1 (de)	2009-03-15
ES2322212T3 (es)	2009-06-17
EP1027063A1 (fr)	2000-08-16
JP2011046723A (ja)	2011-03-10
CA2304952C (fr)	2012-01-03
JP5192020B2 (ja)	2013-05-08
DE69840578D1 (de)	2009-04-02
WO1999016455A1 (fr)	1999-04-08
AU754065B2 (en)	2002-11-07
AU9455598A (en)	1999-04-23
JP2001517709A (ja)	2001-10-09

Publication	Publication Date	Title
DK1027063T3 (da)	2009-06-02	Mannosereceptorbærende cellelinje og antigensammensætning
AU560045B2 (en)	1987-03-26	Latex graft copolymer containing aldehyde realtive with biological agents
MY101593A (en)	1991-12-17	Sustained release preparation.
ATE186632T1 (de)	1999-12-15	Verabreichung einer substanz in den mund
ATE255382T1 (de)	2003-12-15	Stent aus einer formgedächnislegierung
ATE199096T1 (de)	2001-02-15	Il-11 aus säugetier
WO1995034320A3 (fr)	1996-01-18	Procedes d'inhibition des reponses des lymphocytes t specifiques a un antigene
ES2073394T3 (es)	1995-08-16	Constructos de anticuerpos bifuncionales y su utilizacion para destruir selectivamente las poblaciones celulares.
DE3783073D1 (de)	1993-01-28	Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.
ATE258560T1 (de)	2004-02-15	Antikörper die den monozyten chemolockstoff protein 1 (mcp-1) rezeptor (ccr2) binden
EP2377548A3 (fr)	2012-10-10	Isolement et/ou conservation de cellules dendritiques pour l'immunothérapie du cancer de la prostate
CO4810339A1 (es)	1999-06-30	Nuevas estructuras artificiales de proteinas de fusion y metodo de preparacion
DE58907564D1 (de)	1994-06-01	Polymer-gebundene-Farbstoffe, Verfahren zu deren Herstellung und Verwendung.
TR200001021T2 (tr)	2000-09-21	Aktif maddelerin kontrollü salınması için biyo aşındırılabilir makromerler.
TR199801179T2 (xx)	1998-10-21	Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
DK1137436T3 (da)	2008-10-13	Stimulering af T-celler mod selvantigener under anvendelse af CTLA-4-blokeringsmidler
YU49314B (sh)	2005-06-10	Postupak za pripremanje 1-(2'-deoksi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-on)hidrohlorida
NO20010021L (no)	2001-03-07	Trifunksjonelt reagens for konjugering til et biomolekyl
NO971341D0 (no)	1997-03-21	Promoter for reseptor tyrosinkinase TIE
ES2095154T3 (es)	1997-02-01	Alquilglicosidos en tintes.
TR199601037A2 (tr)	1997-07-21	Suda cözülebilir azo boyarmaddeleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmasi.
IL86865A (en)	1993-06-10	Diagnostic method for assessing defects in rna-ase l in a cytoplasmic extract of a patient's mononuclear cells
EP1211311A3 (fr)	2003-11-05	Lymphocytes activés issus du sang de cordon ombilical et compositions contenant ces lymphocytes
DK0752102T3 (da)	2001-01-08	Immunoenzymatisk konjugat, fremgangsmåde til fremstilling af konjugatet og anvendelse af dette.
ATE175971T1 (de)	1999-02-15	Wasserlösliche retinoide